The Kunitz domain I of hepatocyte growth factor activator inhibitor-2 is important for suppressing matriptase activity and human prostate cancer cell invasion

被引:0
|
作者
Wu, Shang-Ru [2 ]
Huang, Hsiang-Po [3 ]
Teng, Chen-Hsin [2 ]
Tu, Ya-Ting [2 ]
Ko, Chun-Jung [2 ]
Lan, Shao-Wei [2 ]
Lin, Hsin-Ying [2 ]
Lin, Hsin-Hsien [2 ]
Tu, Hsin-Fang [2 ]
Hsiao, Pei-Wen [1 ]
Lee, Ming-Shyue [2 ]
机构
[1] Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan
[2] Natl Taiwan Univ, Dept Biochem & Mol Biol, Coll Med, Taipei, Taiwan
[3] Natl Taiwan Univ, Coll Med, Grad Inst Med Genom & Prote, Taipei, Taiwan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:508 / 508
页数:1
相关论文
共 50 条
  • [41] Regulation of the Matriptase-Prostasin Cell Surface Proteolytic Cascade by Hepatocyte Growth Factor Activator Inhibitor-1 during Epidermal Differentiation
    Chen, Ya-Wen
    Wang, Jehng-Kang
    Chou, Feng-Pai
    Chen, Chiu-Yuan
    Rorke, Ellen A.
    Chen, Li-Mei
    Chai, Karl X.
    Eckert, Richard L.
    Johnson, Michael D.
    Lin, Chen-Yong
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (41) : 31755 - 31762
  • [42] Engineering Kunitz Domain of Human Tissue Factor Pathway Inhibitor-2 to Selectively Inhibit Fibrinolysis: An Antifibrinolytic Agent with Potential to Replace Aprotinin
    Bajaj, Madu S.
    Ogueli, Godwin I.
    Schmidt, Amy E.
    Shanker, Sreejesh
    Bajaj, S. Paul
    BLOOD, 2008, 112 (11) : 15 - 15
  • [43] Structure-function analysis of the reactive site in the first Kunitz-type domain of human tissue factor pathway inhibitor-2
    Chand, HS
    Schmidt, AE
    Bajaj, SP
    Kisiel, W
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (17) : 17500 - 17507
  • [44] Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion
    Iochmann, Sophie
    Blechet, Claire
    Chabot, Valerie
    Saulnier, Annabelle
    Amini, Anica
    Gaud, Guillaume
    Gruel, Yves
    Reverdiau, Pascale
    CLINICAL & EXPERIMENTAL METASTASIS, 2009, 26 (05) : 457 - 467
  • [45] Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion
    Sophie Iochmann
    Claire Bléchet
    Valérie Chabot
    Annabelle Saulnier
    Aniça Amini
    Guillaume Gaud
    Yves Gruel
    Pascale Reverdiau
    Clinical & Experimental Metastasis, 2009, 26 : 457 - 467
  • [46] Matriptase, proteinase-activated receptor-2 and hepatocyte growth factor activator inhibitor-1 in skin carcinoma development and progression
    Bocheva, G.
    Rattenholl, A.
    Lin, C. Y.
    Steinhoff, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 84 - 84
  • [47] Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells
    Lee, MS
    Kiyomiya, K
    Benaud, C
    Dickson, RB
    Lin, CY
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2005, 288 (04): : C932 - C941
  • [48] ANNEXIN A5 INHIBITS CELL PROLIFERATION THROUGH REGULATION OF PLASMINOGEN ACTIVATOR INHIBITOR-2 (PAI-2) IN HUMAN PROSTATE CANCER CELLS
    Shin, Dong-Won
    Kwon, Yeo-Jung
    Ye, Dong-Jin
    Shin, Sangyun
    Baek, Hyoung-Seok
    Chun, Young-Jin
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S58 - S59
  • [49] The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer
    Nakamura, Keiichiro
    Hongo, Atsushi
    Kodama, Junichi
    Hiramatsu, Yuji
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (11) : 2613 - 2624
  • [50] Tissue factor pathway inhibitor-2 inhibits the growth and invasion of hepatocellular carcinoma cells and is inactivated in human hepatocellular carcinoma
    Xu, Yong
    Qin, Xiaolin
    Zhou, Jinjing
    Tu, Zhiguang
    Bi, Xiao
    Li, Wuxian
    Fan, Xiaoqing
    Zhang, Yi
    ONCOLOGY LETTERS, 2011, 2 (05) : 779 - 783